StockCIK 1867096
Xeris Biopharma Holdings, Inc. (XERS): Insider Trades and Fund Holdings
In the past 12 months, Xeris Biopharma Holdings, Inc. insiders reported 0 open-market purchases worth $0 and 7 sales worth $906K; 7 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$906KSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 2, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 2 | Beth HechtSee Remarks | ▼ SELL10b5-1 | $157K |
| Oct 2 | Kevin McCullochSee Remarks | ▼ SELL10b5-1 | $141K |
| Oct 2 | Steven PieperSee Remarks | ▼ SELL10b5-1 | $47K |
| Sep 29 | Kevin McCullochSee Remarks | ▼ SELL10b5-1 | $250K |
| Sep 1 | Beth HechtSee Remarks | ▼ SELL10b5-1 | $141K |
| Sep 1 | Kevin McCullochSee Remarks | ▼ SELL10b5-1 | $127K |
| Sep 1 | Steven PieperSee Remarks | ▼ SELL10b5-1 | $43K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Beth Hecht | See Remarks | 0 | $0 | 2 | $298K |
| Kevin McCulloch | See Remarks | 0 | $0 | 3 | $518K |
| Steven Pieper | See Remarks | 0 | $0 | 2 | $90K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report XERS
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 67,337 | $533K | ▼ −85.1% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →